Definitive Contract HHSN261200622016C

Ash Stevens LLC was awarded a definitive contract with a ceiling value of $19.0M by a federal agency to synthesize bulk chemicals and drugs for preclinical and clinical studies. The contract, awarded July 1, 2003, was structured as a cost-plus-fixed-fee arrangement with a completion date of July 30, 2006. Work was performed at the contractor's facility in Detroit, Michigan. This contract was not designated as a set-aside procurement. The contract supported the development and manufacturing of...

This federal contract award was made by the National Institutes of Health (NIH) to Pharmacal Research Laboratories, Inc., a for-profit manufacturer of goods headquartered in Waterbury, Connecticut. The $20,238.01 firm-fixed-price contract was issued as a Blanket Purchase Agreement (BPA) call under a larger $100 million BPA between Pharmacal and the NIH Office of Logistics and Acquisition Operations, which runs from November 29, 2023, to November 30, 2025. The contract is for the supply of...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to On Demand Pharmaceuticals Inc. The contract is for the development of small manufacturing systems to produce research-grade pharmaceutical intermediates, under SBIR Topic 024. The contract is a firm-fixed-price definitive contract with a ceiling value of $325,000.00 and an ultimate completion date...

The Food and Drug Administration (FDA) awarded a $3 million cost-plus-no-fee definitive contract to the National Institute for Pharmaceutical Technology & Education Inc. (NIPTE) to conduct research and development on continuous drug substance manufacturing from biomass-derived building blocks. The award, made on September 22, 2022, through the FDA's Broad Agency Announcement mechanism, supports the agency's broader regulatory science initiative to develop new tools, standards, and approaches...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to A1 Biochem Labs LLC, a small business, for the purchase of 34 intermediate chemical compounds in 5g quantities with purity greater than 95%. The total potential value of the award is $112,350.00. This requirement was set aside for total small business participation and is part of the agency's Coronavirus COVID-19...

Pharmacal Research Laboratories, Inc., a Connecticut-based manufacturer of animal environmental control products and laboratory supplies, was awarded a Blanket Purchase Agreement (BPA) call valued at $23,170.38 by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health. The award, issued on June 8, 2012, with an ultimate completion date of November 30, 2012, utilized firm fixed-price pricing and carried no small business set-aside...

This $16,035 firm-fixed price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a New Jersey-based foreign-owned minority-owned small business. The award is for the acquisition of 2 grams of Minnelide (CAS: 1254702-87-8) and 10 grams of GNE-618 (CAS: 1362151-42-5), which are chemical compounds used to support NCATS' biomedical research programs. MedChemExpress has...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $99,000 firm fixed price purchase order to Targetmol Chemicals Inc. to synthesize analogs of repsox and intermediates from two ongoing medicinal chemistry projects. Over a six-month period after receipt of order, Targetmol will synthesize the requested compounds and deliver milligram to gram quantities to NCATS along with electronic progress reports, analytical data including LCMS and 1H NMR, and...

On March 17, 2016, the Office of the Director awarded a Blanket Purchase Agreement (BPA) call valued at $6,000 to Sigma-Aldrich, Inc. (doing business as Sigma-Aldrich Sales, Inc.) for laboratory supply procurement. The contract, which utilized firm fixed-price pricing with no small business set-aside designation, was completed on March 23, 2016, with performance taking place in Bethesda, Maryland. Sigma-Aldrich, a foreign-owned life sciences and high-technology company headquartered in St....

The National Center for Advancing Translational Sciences (NCATS) awarded a $739,894 firm fixed-price purchase order to Mriglobal (doing business as Midwest Research Institute) on September 16, 2025, for the procurement of API and diluent. The contract, which carries no set-aside designation, is scheduled for completion by September 19, 2028, and will be performed in Potomac, Maryland. Mriglobal is a Kansas City-based 501(c)(3) not-for-profit research organization with over $110 million in annual...